Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Celldex Therapeutics, Inc. - Common Stock (NQ:CLDX)

28.53 -1.62 (-5.37%)
Delayed Quote Updated: 4:00 PM EST, Nov 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Celldex Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
Crude Oil Rises 6%; US Consumer Sentiment Surges In June ↗
 
Via Benzinga
News headline image
Unusual Machines, Celldex Therapeutics, RH And Other Big Stocks Moving Higher On Friday ↗
 
Via Benzinga
News headline image
Forecasting The Future: 8 Analyst Projections For Celldex Therapeutics ↗
 
Via Benzinga
News headline image
Analyst Expectations For Celldex Therapeutics's Future ↗
 
Via Benzinga
News headline image
This Kohl's Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Monday ↗
 
Via Benzinga
News headline image
Forecasting The Future: 6 Analyst Projections For Celldex Therapeutics ↗
 
Via Benzinga
News headline image
Demystifying Celldex Therapeutics: Insights From 6 Analyst Reviews ↗
 
Via Benzinga
News headline image
7 Analysts Have This To Say About Celldex Therapeutics ↗
 
Via Benzinga
News headline image
This Microsoft Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday ↗
 
Via Benzinga
News headline image
Baidu, Informatica And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Jasper Therapeutics Skin Disorder Candidate Data Fails To Cheer Investors ↗
Jasper Therapeutics reports strong briquilimab efficacy in CSU with UAS7 reductions, dose-dependent responses, and Phase 2b plans by late 2025. 
Via Benzinga
News headline image
What Analysts Are Saying About Celldex Therapeutics Stock ↗
 
Via Benzinga
News headline image
Beyond The Numbers: 11 Analysts Discuss Celldex Therapeutics Stock ↗
 
Via Benzinga
News headline image
Analyst Expectations For Celldex Therapeutics's Future ↗
 
Via Benzinga
News headline image
A Closer Look at 10 Analyst Recommendations For Celldex Therapeutics ↗
 
Via Benzinga
News headline image
This HP Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday ↗
 
Via Benzinga
News headline image
The Analyst Verdict: Celldex Therapeutics In The Eyes Of 7 Experts ↗
 
Via Benzinga
News headline image
7 Analysts Have This To Say About Celldex Therapeutics ↗
 
Via Benzinga
News headline image
CLDX Stock Earnings: Celldex Therapeutics Beats EPS, Beats Revenue for Q2 2024 ↗
CLDX stock results show that Celldex Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
Lattice Semiconductor Posts Weak Q2 Results, Joins Symbotic, Woodward And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Analyst Expectations For Celldex Therapeutics's Future ↗
 
Via Benzinga
News headline image
Analyst Expectations For Celldex Therapeutics's Future ↗
 
Via Benzinga
News headline image
Unveiling 4 Analyst Insights On Celldex Therapeutics ↗
 
Via Benzinga
News headline image
Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
 
Via Benzinga
News headline image
Why F5 Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
ViaSat & AST SpaceMobile Are Among Top 6 Mid Cap Stocks That Shined The Brightest Last Week (July 21-July 27): Are The Others In Your Portfolio? ↗
Top mid-cap stocks of the week: ASTS up 47.88%, GSHD up 39.86%, VSAT up 30.78%, VKTX up 29.86%, BEAM up 23.93%, CLDX up 19.72% 
Via Benzinga
News headline image
CLDX Stock Earnings: Celldex Therapeutics Beats EPS, Misses Revenue for Q1 2024 ↗
CLDX stock results show that Celldex Therapeutics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Cooper Companies Reports Upbeat Results, Joins Dell, NetApp, Tidewater And Other Big Stocks Moving Higher On Friday ↗
U.S. stocks were higher, with the Nasdaq Composite gaining around 0.5% on Friday. 
Via Benzinga
Topics Stocks
News headline image
Why Freshpet Shares Are Trading Higher By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Shares of Freshpet, Inc. (NASDAQ: FRPT) gained 15.5% to $106.29 after the company reported better-than-expected fourth-quarter financial results. 
Via Benzinga
News headline image
Celldex Stock Hits 11-Month High, Up 19%, On A Promising New Hives Treatment ↗
The company tested its treatment in chronic spontaneous urticaria. Almost 38% of patients had "complete control" after 12 weeks. 
Via Investor's Business Daily
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.